UP govt allows trial of Covaxin in Lucknow and Gorakhpur

Uttar Presh Government on Wednesday allowed phase-3 trial of anti-COVID-19 vaccine ''Covaxin'' in Luckw and Gorakhpur. vaccine is currently being tested by Bharat Biotech Ltd in collaboration with Indian Council of Medical Research (ICMR).

ditional Chief Secretary (Medical and Health) Amit Mohan Pras conveyed government’s permission to test anti-COVID-19 vaccine in two cities through a letter to Bharat Biotech International Limited’s director V Krishna Mohan.

"Kindly refer to your letter dated September 19, 2020 for permission and facilitation to initiate COVAXIN Phase 3 Efficacy and Safety clinical trials in Uttar Presh. It has been decided to allow Bharat Biotech to conduct Phase-3 trial in Luckw and Gorakhpur," Pras said in his letter.

"All permission will have to be obtained by you and all safety and or protocols will have to be followed as per guidelines of Government of India for conducting clinical trials," he ded in letter.

For Luckw, Dr R K Dhiman, director of Sanjay Gandhi Post Gruate Institute of Medical Sciences has been me dal person, while for Gorakhpur, Dr Ganesh Kumar, Principal of BRD Medical College has been me dal officer.